Cargando…

Construction of ratiometric Si-Mn:ZnSe nanoparticles for the immunoassay of SARS-CoV-2 spike protein

The continuing global spread of Coronavirus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection, has led to an unprecedented global health crisis. Effective and affordable methods are needed to diagnose SARS-CoV-2 infection. In this work, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Guobin, Li, Yifang, Wu, Guoqiang, Ye, Silu, Cao, Shijie, Zhao, Wei, Lu, Junnan, Dai, Junbiao, Ma, Yingxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250813/
https://www.ncbi.nlm.nih.gov/pubmed/35813462
http://dx.doi.org/10.1016/j.snb.2022.132306
_version_ 1784739882715840512
author Mao, Guobin
Li, Yifang
Wu, Guoqiang
Ye, Silu
Cao, Shijie
Zhao, Wei
Lu, Junnan
Dai, Junbiao
Ma, Yingxin
author_facet Mao, Guobin
Li, Yifang
Wu, Guoqiang
Ye, Silu
Cao, Shijie
Zhao, Wei
Lu, Junnan
Dai, Junbiao
Ma, Yingxin
author_sort Mao, Guobin
collection PubMed
description The continuing global spread of Coronavirus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection, has led to an unprecedented global health crisis. Effective and affordable methods are needed to diagnose SARS-CoV-2 infection. In this work, a ratiometric fluorescence probe, Si-Mn:ZnSe nanoparticles, was constructed through the electrostatic interaction between Si dots and Mn:ZnSe QDs, and the fluorescence of Mn:ZnSe QDs has a specifical response to H(2)O(2). An immunocomplex was formed by the recognition of capture antibody/spike (S) protein/spike neutralizing antibody/biotinylated second antibody/streptavidin/biotinylated catalase (CAT). In the presence of S protein, CAT effectively catalyzed the decomposition of H(2)O(2) in the system, and the fluorescence of Mn:ZnSe QDs was not specifically quenched. Based on this principle, a ratiometric immunoassay of SARS-CoV-2 S protein was established. The sensitivity of the proposed ELISA method was comparable to that of the commercial kit. In addition, this method can effectively distinguish the pseudo-SARS-CoV-2 virus and other pseudovirus. Therefore, this method provided a reliable and potential direction for diagnosing SARS-CoV-2 infection.
format Online
Article
Text
id pubmed-9250813
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-92508132022-07-05 Construction of ratiometric Si-Mn:ZnSe nanoparticles for the immunoassay of SARS-CoV-2 spike protein Mao, Guobin Li, Yifang Wu, Guoqiang Ye, Silu Cao, Shijie Zhao, Wei Lu, Junnan Dai, Junbiao Ma, Yingxin Sens Actuators B Chem Article The continuing global spread of Coronavirus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection, has led to an unprecedented global health crisis. Effective and affordable methods are needed to diagnose SARS-CoV-2 infection. In this work, a ratiometric fluorescence probe, Si-Mn:ZnSe nanoparticles, was constructed through the electrostatic interaction between Si dots and Mn:ZnSe QDs, and the fluorescence of Mn:ZnSe QDs has a specifical response to H(2)O(2). An immunocomplex was formed by the recognition of capture antibody/spike (S) protein/spike neutralizing antibody/biotinylated second antibody/streptavidin/biotinylated catalase (CAT). In the presence of S protein, CAT effectively catalyzed the decomposition of H(2)O(2) in the system, and the fluorescence of Mn:ZnSe QDs was not specifically quenched. Based on this principle, a ratiometric immunoassay of SARS-CoV-2 S protein was established. The sensitivity of the proposed ELISA method was comparable to that of the commercial kit. In addition, this method can effectively distinguish the pseudo-SARS-CoV-2 virus and other pseudovirus. Therefore, this method provided a reliable and potential direction for diagnosing SARS-CoV-2 infection. Elsevier B.V. 2022-10-15 2022-07-03 /pmc/articles/PMC9250813/ /pubmed/35813462 http://dx.doi.org/10.1016/j.snb.2022.132306 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Mao, Guobin
Li, Yifang
Wu, Guoqiang
Ye, Silu
Cao, Shijie
Zhao, Wei
Lu, Junnan
Dai, Junbiao
Ma, Yingxin
Construction of ratiometric Si-Mn:ZnSe nanoparticles for the immunoassay of SARS-CoV-2 spike protein
title Construction of ratiometric Si-Mn:ZnSe nanoparticles for the immunoassay of SARS-CoV-2 spike protein
title_full Construction of ratiometric Si-Mn:ZnSe nanoparticles for the immunoassay of SARS-CoV-2 spike protein
title_fullStr Construction of ratiometric Si-Mn:ZnSe nanoparticles for the immunoassay of SARS-CoV-2 spike protein
title_full_unstemmed Construction of ratiometric Si-Mn:ZnSe nanoparticles for the immunoassay of SARS-CoV-2 spike protein
title_short Construction of ratiometric Si-Mn:ZnSe nanoparticles for the immunoassay of SARS-CoV-2 spike protein
title_sort construction of ratiometric si-mn:znse nanoparticles for the immunoassay of sars-cov-2 spike protein
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250813/
https://www.ncbi.nlm.nih.gov/pubmed/35813462
http://dx.doi.org/10.1016/j.snb.2022.132306
work_keys_str_mv AT maoguobin constructionofratiometricsimnznsenanoparticlesfortheimmunoassayofsarscov2spikeprotein
AT liyifang constructionofratiometricsimnznsenanoparticlesfortheimmunoassayofsarscov2spikeprotein
AT wuguoqiang constructionofratiometricsimnznsenanoparticlesfortheimmunoassayofsarscov2spikeprotein
AT yesilu constructionofratiometricsimnznsenanoparticlesfortheimmunoassayofsarscov2spikeprotein
AT caoshijie constructionofratiometricsimnznsenanoparticlesfortheimmunoassayofsarscov2spikeprotein
AT zhaowei constructionofratiometricsimnznsenanoparticlesfortheimmunoassayofsarscov2spikeprotein
AT lujunnan constructionofratiometricsimnznsenanoparticlesfortheimmunoassayofsarscov2spikeprotein
AT daijunbiao constructionofratiometricsimnznsenanoparticlesfortheimmunoassayofsarscov2spikeprotein
AT mayingxin constructionofratiometricsimnznsenanoparticlesfortheimmunoassayofsarscov2spikeprotein